Low-dose paclitaxel modulates tumour fibrosis in gastric cancer. - Wikidata - awgldk - TriplyDB

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

http://www.wikidata.org/entity/Q39188081

about

Paclitaxel: new uses for an old drug.Intravital Microscopy Imaging Approaches for Image-Guided Drug Delivery Systems Transforming growth factor-β1 regulates epithelial-mesenchymal transition in association with cancer stem-like cells in a breast cancer cell line Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states Cathelicidin suppresses colon cancer development by inhibition of cancer associated fibroblasts Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast.Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells.Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target.Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil

P2860

Q27691306-CA7693AD-3210-48A2-A3E3-4EA8E2E20DB4 Q28553638-E1E92DC3-42DA-4350-935D-1F6AE5B11346 Q33756214-F91CE8FB-FDFC-4F05-B580-F10E7519D2BE Q34406761-5D0CE3D2-DB42-43BA-946A-12184FD132B0 Q34757218-37CE1F8A-97D8-4BCA-A865-4634C066A3E2 Q35012479-1D579019-955D-45F8-8154-BD5E468C5CA8 Q37138570-F04751CA-FBEB-4367-B2D6-9E9FD5553A41 Q37338767-000C2B77-CB6D-49F7-AC86-ABD3798382D3 Q41110002-3C8A8855-7887-4EF2-8CF8-E81E27599FB5 Q47101405-D5C93DA1-0FC0-4142-84B6-E3C6D2F82ACB Q49747089-A77AD4AD-C60E-4B11-9A2B-0B3722F1957F Q55339193-B0E4C6D1-DE1E-4E85-92C9-414B6FA98D4D Q58777726-D84AD4F1-0229-4ED6-9296-5FF7AF031D10

P2860

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

http://www.wikidata.org/entity/Q39188081

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@en

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@nl

type

label

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@en

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@nl

prefLabel

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@en

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@nl

P1433

Q39188081-41A8AB85-B018-4C9E-AEAB-E9CC56D0825A

P1476

Q39188081-34490A39-FE7D-4458-BE8E-FF25C9CC5F2C

P2093

Q39188081-1518EC81-8D97-41F9-8BB4-F358FADF6ACD

Q39188081-3263AD3F-C149-43BC-8A1C-1E1A6ED14172

Q39188081-55EF7AAC-D3BF-40FF-B91D-E2572B81637B

Q39188081-597BFE94-624C-4D7A-A4A7-505EDA836895

Q39188081-77BD8F22-26D4-4D96-88A2-1EC50ACD8FFD

Q39188081-AABAAA2D-4AA0-47E2-A7CB-5D8BD67D1F85

Q39188081-AF87F1DE-BD4B-479F-AA8F-D3494816803D

Q39188081-B57473D2-0CD4-432D-A8A5-91A1747CF71F

Q39188081-BA3DAF6F-09BC-4F30-803F-04793F1CE6A5

Q39188081-E51E0418-D9CE-4EC5-A5B6-8A1083815C8C

P2860

Q39188081-016A82BB-E89F-4ECD-9668-691ED358FF82

Q39188081-03FBB4A7-D185-4212-A56B-59D9F1A916C6

Q39188081-046CB380-4EA6-43E5-8F6C-4AECDCB45214

Q39188081-08B27198-A97D-4314-8514-519D3E47ADD2

Q39188081-0B387061-E666-4AD6-8FCA-1C3306C5FDD4

Q39188081-0D0568E3-13C0-4D3F-9978-95BDDE7CDE42

Q39188081-0FDB4971-B302-4046-8758-37720AB7A9F9

Q39188081-13DE09FF-5509-4D20-B810-CB6F5F210FD3

Q39188081-166BC0B7-4AF1-44E9-B59F-C79EDE933A4F

Q39188081-1AB08238-1A73-46C9-BA17-DAD3F7465A8B

P304

Q39188081-CE19FDA4-ED29-4624-946A-99E07B4C64BC

P31

Q39188081-298E32FE-90FE-4E97-9957-13E4FF772788

P356

Q39188081-26DB503F-7779-49B3-8079-CD9DFCDD4D90

P433

Q39188081-547AAFBF-2D79-48E2-A693-E2F8E3039706

P478

Q39188081-5645228A-8480-4249-BEFD-3BB00D0E0098

P577

Q39188081-A5543911-5F38-4090-A0FC-08986262AE54

P5875

Q39188081-D720EDDF-8C81-4AA1-8341-73B4F1B6A12E

P698

Q39188081-C2B4058C-5081-4914-B2A5-C333F7AD1856

P932

Q39188081-6B0626EC-ABD2-41C0-AED6-E72F6F13D5E4

P356

P1433

International Journal of Oncology

P1476

Low-dose paclitaxel modulates tumour fibrosis in gastric cancer.

@en

P2093

Hidehiro Tajima

http://www.w3.org/2001/XMLSchema#string

Itasu Ninomiya

http://www.w3.org/2001/XMLSchema#string

Jun Kinoshita

http://www.w3.org/2001/XMLSchema#string

Katsunobu Oyama

http://www.w3.org/2001/XMLSchema#string

Sachio Fushida

http://www.w3.org/2001/XMLSchema#string

Shinichi Harada

http://www.w3.org/2001/XMLSchema#string

Shiroh Terai

http://www.w3.org/2001/XMLSchema#string

Takashi Fujimura

http://www.w3.org/2001/XMLSchema#string

Tetsuo Ohta

http://www.w3.org/2001/XMLSchema#string

Tomoya Tsukada

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transition and its implications for fibrosis

Paclitaxel modulates TGFbeta signaling in scleroderma skin grafts in immunodeficient mice.

A structural basis for mutational inactivation of the tumour suppressor Smad4

Epithelial-mesenchymal transitions in tumour progression

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

An overview of epithelio-mesenchymal transformation

Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.

P304

1167-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2013.1801

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235740840

http://www.w3.org/2001/XMLSchema#string

P698

23443842

http://www.w3.org/2001/XMLSchema#string

P932

3622657

http://www.w3.org/2001/XMLSchema#string